ArticleFrontiers in immunology2019

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients.

Michal Bassani-Sternberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.